Connect with us

Business

Chinese Smart Glasses Companies Target Global Markets – SUCH TV

Published

on

Chinese Smart Glasses Companies Target Global Markets – SUCH TV



In China, AI-powered smart glasses now allow wearers to make payments in shops with just a glance at a QR code and a simple voice command, as more companies set their sights on both domestic and international markets.

After over a decade of limited progress, interest in smart eyewear is surging worldwide, driven by advances in artificial intelligence that have revitalized the sector.

While U.S. tech giant Meta currently leads the global market, a range of Chinese companies from major players like Alibaba and Xiaomi to startups such as Rokid and XREAL—are working to catch up.

“China’s advantages are self-evident,” Rokid CEO Misa Zhu told AFP after a recent launch in Hangzhou. “The ecosystem and supply chain are all in China, and production is strong.”

Chinese firms enjoy a significant domestic edge, as Meta’s services are largely inaccessible without a VPN. The country also represents a potentially huge and lucrative market for wearable technology.

Smart glasses sales in China are projected to grow by 116 percent year-on-year in 2025, according to market research firm IDC. Daily life in China is highly digitalized, with even older citizens routinely using smartphones for payments, transport, and other services.

Zhu added that China’s digital infrastructure, including widespread QR code payment systems, is already more advanced than in Europe or the United States, giving local companies a strategic advantage in developing and selling smart eyewear.

‘Dark horse’ Xiaomi

Other Chinese companies like Xiaomi, RayNeo, Thunderobot and Kopin are active players in the smart glasses sector, wrote Flora Tang, an analyst at research firm Counterpoint.

Xiaomi in particular was a “dark horse”, she said, its debut AI glasses the third best-selling of their kind for the first half of 2025 despite only being on sale for about a week.

Interest is also being shown in smaller companies like Rokid, with the company raising more than $4 million on crowdfunding site Kickstarter recently.

Rokid is “observing and learning… from big global companies”, CEO Zhu said.

To straddle the domestic and overseas markets, the firm allows customers to use Chinese apps in China, and others elsewhere, unlike competitors like Meta, which limit the apps on offer.

The Rokid glasses are not locked to one generative AI model, either.

“We are very open that we use OpenAI, and can also connect with Llama, Gemini, and Grok” Zhu said.

“That’s why many people like us.”

Another feature Rokid demonstrated in Hangzhou was simultaneous translation, featuring phosphor-green English subtitles that rolled across the glasses’ inner lenses as an employee talked in Chinese.

But shattering Meta’s dominance overseas will be challenging.

In the first half of 2025, Meta commanded a 73 percent share of the growing global smart glasses market, according to Counterpoint.

Its success has been attributed to the Ray-Ban Meta Smart Glasses, almost indistinguishable from everyday, and crucially fashionable, eyewear.

Privacy concerns

In Hangzhou, Rokid unveiled new collaborations with Bolon, which is also owned by Ray-Ban’s parent company EssilorLuxottica.

With weight also a crucial factor, Rokid says its models are among the world’s lightest.

“Appearance remains the top priority — it has to make people actually want to wear it,” 25-year-old customer Wu Tianhao told AFP.

Chinese firms showcase “numerous brands and models, rapid iteration, and ability to quickly adapt to market changes”, industry expert Zhu Dianrong said.

However, “overseas brands still hold an advantage in hard tech like full-colour displays and optical waveguides”.

Rokid’s vice president Gary Cai acknowledged an “obvious gap” in chip technology available in China and overseas, but noted the difference between AI models “has narrowed considerably”.

Despite interest in smart glasses rising, Chinese and foreign firms alike face major challenges ahead of widespread adoption.

Across the board, the user experience needs more polish and accessibility, said Will Greenwald, writer for consumer electronics outlet PCMag.

“I don’t think anyone has really made it a smooth experience just yet,” he told AFP.

Privacy concerns remain a hurdle, with the ramifications of widely worn glasses discreetly and near-constantly recording throwing up potential regulatory pitfalls.

Still, manufacturers such as Zhu remain confident.

“Today, our AI glasses are phone peripherals,” he said. “But in the near future… phones will become accessories to the glasses.”



Source link

Business

Home heating oil: ‘Most of my pension has gone on home heating oil’

Published

on

Home heating oil: ‘Most of my pension has gone on home heating oil’



Rising heating oil prices are hitting Northern Ireland harder than the rest of the UK – here’s everything you need to know.



Source link

Continue Reading

Business

FDA vaccine head will step down in April after string of controversial decisions

Published

on

FDA vaccine head will step down in April after string of controversial decisions


The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, April 22, 2025.

Nathan Posner | Anadolu | Getty Images

A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the agency following multiple decisions that raised concerns within the industry.

Vinay Prasad, director of the Center for Biologics Evaluation and Research, will leave the FDA at the end of April, an agency spokesperson confirmed on Friday. It is his second departure from the position: He briefly left the post in July following backlash over his regulatory decisions, and returned only two weeks later in August.

In a post on X, FDA Commissioner Marty Makary said the FDA will appoint a successor before Prasad returns next month to the University of California San Francisco, where he taught before taking the FDA position last year. Makary said Prasad “got a tremendous amount accomplished” during his tenure at the agency.

Prasad’s decision to step down comes after criticism of the FDA mounted within the biotech and pharmaceutical industry and among former health officials. In the past year, the agency has denied or discouraged the approval applications of at least eight drugs, according to RTW Investments, after taking issue with data the companies used to support their applications. The FDA also initially refused to review Moderna’s flu shot before it later reversed course.

All of those companies accused the FDA of reversing previous guidance about the evidence they could use to back their applications, sparking criticism within the industry that an unreliable regulatory process could stifle development of drugs for hard-to-treat diseases.

A former FDA official who spoke to CNBC on the condition of anonymity to speak freely on the issue called the reversals the worst kind of regulatory uncertainty because companies say they are being told one thing and then experience another.

In a statement earlier Friday, an FDA spokesperson said there was “no regulatory uncertainty,” adding the agency “makes decisions based on the evidence, but does not make assurances about outcomes.” The spokesperson said the FDA is “conducting rigorous, independent reviews and not rubber-stamping approvals.”

The most recent controversy came after the FDA discouraged UniQure from applying for expedited approval of its experimental treatment for Huntington’s disease.

The agency, which underwent staff cuts and an overhaul under Health and Human Services Secretary Robert F. Kennedy Jr., has faced broader backlash for its drug and vaccine approvals process. Critics have worried the agency could stifle the development of new treatments and risk the safety of patients.

The Wall Street Journal earlier reported Prasad’s departure.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source link

Continue Reading

Business

Oil price at two-year high after Qatar minister warns all Gulf production could stop

Published

on

Oil price at two-year high after Qatar minister warns all Gulf production could stop



Energy Minister Saad al-Kaabi says oil could hit $150 a barrel if the Iran conflict continues over the coming weeks.



Source link

Continue Reading

Trending